These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20418958)

  • 1. Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.
    Ruchala P; Navab M; Jung CL; Hama-Levy S; Micewicz ED; Luong H; Reyles JE; Sharma S; Waring AJ; Fogelman AM; Lehrer RI
    PLoS One; 2010 Apr; 5(4):e10181. PubMed ID: 20418958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
    Van Lenten BJ; Wagner AC; Jung CL; Ruchala P; Waring AJ; Lehrer RI; Watson AD; Hama S; Navab M; Anantharamaiah GM; Fogelman AM
    J Lipid Res; 2008 Nov; 49(11):2302-11. PubMed ID: 18621920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.
    Wool GD; Vaisar T; Reardon CA; Getz GS
    J Lipid Res; 2009 Sep; 50(9):1889-900. PubMed ID: 19433476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
    Datta G; Chaddha M; Hama S; Navab M; Fogelman AM; Garber DW; Mishra VK; Epand RM; Epand RF; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM
    J Lipid Res; 2001 Jul; 42(7):1096-104. PubMed ID: 11441137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential clinical utility of high-density lipoprotein-mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
    Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
    Curr Opin Lipidol; 2004 Dec; 15(6):645-9. PubMed ID: 15529023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of apolipoprotein E derived peptide modulate their lipid-binding capacity and influence their anti-inflammatory function.
    Nankar SA; Pande AH
    Biochim Biophys Acta; 2014 Apr; 1841(4):620-9. PubMed ID: 24486429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids.
    Epand RF; Mishra VK; Palgunachari MN; Anantharamaiah GM; Epand RM
    Biochim Biophys Acta; 2009 Sep; 1788(9):1967-75. PubMed ID: 19559666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.
    D'Souza W; Stonik JA; Murphy A; Demosky SJ; Sethi AA; Moore XL; Chin-Dusting J; Remaley AT; Sviridov D
    Circ Res; 2010 Jul; 107(2):217-27. PubMed ID: 20508181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
    Sherman CB; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
    Wool GD; Reardon CA; Getz GS
    J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
    Van Lenten BJ; Wagner AC; Navab M; Anantharamaiah GM; Hui EK; Nayak DP; Fogelman AM
    Circulation; 2004 Nov; 110(20):3252-8. PubMed ID: 15533864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI.
    Song X; Fischer P; Chen X; Burton C; Wang J
    Int J Biol Sci; 2009 Oct; 5(7):637-46. PubMed ID: 19847320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
    Xie Q; Zhao SP; Li F
    Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of HDL mimetics.
    Navab M; Shechter I; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):164-8. PubMed ID: 19608977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity.
    Datta G; Epand RF; Epand RM; Chaddha M; Kirksey MA; Garber DW; Lund-Katz S; Phillips MC; Hama S; Navab M; Fogelman AM; Palgunachari MN; Segrest JP; Anantharamaiah GM
    J Biol Chem; 2004 Jun; 279(25):26509-17. PubMed ID: 15075321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
    Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of HDL mimetic peptide 4F on PON1.
    Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
    Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.